Last edition
News about "formulations manufacturing facility "
Glenmark's Aurangabad Facility Clears US FDA Inspection With Zero Observations
Glenmark Pharmaceuticals announced that the US Food and Drug Administration (US FDA) has successfully completed a pre-approval inspection of its formulations manufacturing facility in Chhatrapati Sambhajinagar (Aurangabad).
Formulations Manufacturing Facility | 01/12/2025 | By Dineshwori | 122
Glenmark Pharmaceuticals Receives EIR from US FDA for Monroe Facility
Glenmark Pharmaceuticals has received an Establishment Inspection Report (EIR) from the US FDA for its formulations manufacturing facility in Monroe, with a Voluntary Action Indicated (VAI) status.
Formulations Manufacturing Facility | 27/11/2025 | By Dineshwori | 116
USFDA Concludes Inspection at Dr. Reddy's Srikakulam Facility with VAI Classification
Dr. Reddy’s Laboratories has announced that the United States Food and Drug Administration (USFDA) has completed a Good Manufacturing Practice (GMP) and Pre-Approval Inspection (PAI) at its formulations manufacturing facility (FTO 11) in Srikakulam, Andhra Pradesh.
Formulations Manufacturing Facility | 21/10/2025 | By Dineshwori | 282
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy